Step One:
Oral Administration in Capsule Form
Vedanta's bacterial consortia therapeutics are easily administered as lyophilized powder in oral capsule form.
Unlike fecal transplants, which require use of donors and are an untargeted, inherently variable procedure, bacterial consortia therapeutics are defined drug compositions produced from clonally isolated bacteria that can trigger targeted immune responses. And unlike reductionistic approaches such as single strain probiotics, they can robustly shift the gut ecosystem.
Our platform enables identification of defined bacterial consortia with drug-like properties and their manufacture to GMP standards.
How Our Proprietary Discovery and Development Platform Works